[Fecal microbiota transplantation as a novel therapy for severe psoriasis]

Zhonghua Nei Ke Za Zhi. 2019 Oct 1;58(10):782-785. doi: 10.3760/cma.j.issn.0578-1426.2019.10.011.
[Article in Chinese]

Abstract

To explore the therapeutic effect of fecal microbiota transplantation (FMT) for severe psoriasis. A patient, male, 36 years old, diagnosed as severe plaque psoriasis for 10 years and irritable bowel syndrome (IBS) for 15 years, was administrated twice FMT via both upper endoscopy and colonoscopy with a 5-week interval. The following items were used to evaluate responses: body surface area (BSA), psoriasis area and severity index (PASI), dermatology life quality index (DLQI), histological examination, intestinal symptoms, adverse reactions and serum level of tumor necrosis factor (TNF)-α. After second FMT treatment for 5 weeks, aforementioned items were improved greatly compared with those before treatment. Moreover, IBS was completely relieved and no adverse reactions were observed during the treatment and follow-up. In conclusion, FMT could be a novel therapy for psoriasis. Further clinical trials are needed to provide solid evidences.

通过肠微生态移植重建(FMT)治疗重度银屑病,探索治疗银屑病的新方法。患者男,36岁,患寻常型银屑病10年,肠易激综合征15年,进行2次胃、肠镜联合FMT治疗。评估治疗前后皮损累及体表面积(BSA)、银屑病面积和严重程度指数(PASI)、生活质量指数(DLQI)、皮肤组织病理、肠道症状、安全性及血清肿瘤坏死因子α等。结果显示,FMT治疗该例银屑病患者临床疗效显著,肠易激综合征临床症状消失,且无不良反应发生。提示FMT可能是治疗银屑病的一种新疗法,值得进一步研究。.

Keywords: Fecal microbiota transplantation; Irritable bowel syndrome; Psoriasis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Endoscopy
  • Fecal Microbiota Transplantation* / trends
  • Feces / microbiology
  • Gastrointestinal Microbiome
  • Humans
  • Intestines
  • Irritable Bowel Syndrome / complications
  • Irritable Bowel Syndrome / microbiology
  • Irritable Bowel Syndrome / psychology
  • Irritable Bowel Syndrome / therapy*
  • Male
  • Psoriasis / psychology
  • Psoriasis / therapy*
  • Quality of Life
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / blood*

Substances

  • Tumor Necrosis Factor-alpha